Global Inhalable Drugs Market Size & Outlook, 2025-2030
Global inhalable drugs market, 2018-2030 (US$M)
Related Markets
Global inhalable drugs market highlights
- The global inhalable drugs market generated a revenue of USD 22,767.0 million in 2024 and is expected to reach USD 32,040.4 million by 2030.
- The market is expected to grow at a CAGR (2025 - 2030) of 5.9% by 2030.
- In terms of segment, dry powder formulation accounted for a revenue of USD 10,062.2 million in 2024.
- Dry powder formulation is the most lucrative product segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2024.
- Country-wise, UAE is expected to register the highest CAGR from 2025 to 2030.
Global data book summary
| Market revenue in 2024 | USD 22,767.0 million |
| Market revenue in 2030 | USD 32,040.4 million |
| Growth rate | 5.9% (CAGR from 2025 to 2030) |
| Largest segment | Dry powder formulation |
| Fastest growing segment | Dry powder formulation |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Aerosol, Dry powder formulation, Spray |
Other key industry trends
- In terms of revenue, the North America accounted for 42.9% of the global inhalable drugs market in 2024.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, UAE is the fastest growing regional market and is projected to reach USD 59.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Inhalable Drugs Market Scope
Inhalable Drugs Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Boehringer Ingelheim Pharma | View profile | 10001+ | Dortmund, Nordrhein-Westfalen, Germany, Europe | https://www.boehringer-ingelheim.de/unternehmensprofil/unser-unternehmen/standort-dortmund |
| Philip Morris International Inc | View profile | 82700 | 677 Washington Boulevard, Suite 1100, Stamford, New York, NY, United States, 06901 | https://www.pmi.com |
| Viatris Inc | View profile | 38000 | 1000 Mylan Boulevard, Canonsburg, PA, United States, 15317 | https://www.viatris.com |
| AstraZeneca PLC | View profile | 89900 | 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AA | https://www.astrazeneca.com |
| Boehringer Ingelheim | View profile | 10001+ | Ingelheim Am Rhein, Rheinland-Pfalz, Germany, Europe | https://www.boehringer-ingelheim.com/ |
| GSK PLC | View profile | 70200 | 980 Great West Road, Brentford, Middlesex, United Kingdom, TW8 9GS | https://www.gsk.com |
| Cipla Ltd DR | View profile | 38955 | Ganpatrao Kadam Marg, Cipla House, Peninsula Business Park, Lower Parel, Mumbai, MH, India, 400 013 | https://www.cipla.com |
| Sanofi SA | View profile | 87994 | 46, avenue de la Grande Armée, Paris, France, 75017 | https://www.sanofi.com |
Global inhalable drugs market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to inhalable drugs market will help companies and investors design strategic landscapes.
Dry powder formulation was the largest segment with a revenue share of 44.2% in 2024. Horizon Databook has segmented the Global inhalable drugs market based on aerosol, dry powder formulation, spray covering the revenue growth of each sub-segment from 2018 to 2030.
- Global Inhalable Drugs Product Outlook (Revenue, USD Million, 2018-2030)
- Spray
- Aerosol
- Dry powder formulation
- Global Inhalable Drugs Application Outlook (Revenue, USD Million, 2018-2030)
- Respiratory diseases
- Non respiratory diseases
Reasons to subscribe to Global inhalable drugs market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global inhalable drugs market databook
-
Our clientele includes a mix of inhalable drugs market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global inhalable drugs market , including forecasts for subscribers. This global databook contains high-level insights into Global inhalable drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global inhalable drugs market size, by regions, 2018-2030 (US$M)
Top 10 countries: Inhalable drugs market size, 2024 (US$M)
Global inhalable drugs market share, by product, 2024 & 2030 (%, US$M)
Inhalable drugs market: Opportunity assessment by country
Global inhalable drugs market, by region, 2024 (US$M)
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
